Vera Mick

Title: Vera Mick: Innovator in Cancer Treatment

Introduction

Vera Mick is a prominent inventor based in Schifferstadt, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic antibodies. Her work focuses on the use of antibodies against the laminin receptor, which plays a crucial role in various cancer types.

Latest Patents

Vera Mick holds a patent for the "Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types." This patent describes the use of a recombinant antibody that specifically binds to an epitope of the laminin receptor or its precursor. The invention aims to improve the treatment and diagnosis of various cancers, particularly B-CLL. The antibody may also include a binding site for at least one specific cell surface antigen, enhancing its therapeutic potential.

Career Highlights

Vera Mick is currently associated with Affimed Therapeutics AG, a company dedicated to developing innovative cancer immunotherapies. Her work at Affimed Therapeutics has positioned her as a key player in the advancement of antibody-based treatments for cancer patients.

Collaborations

Vera has collaborated with notable colleagues, including Melvyn Little and Stefan Knackmuss. These partnerships have contributed to her research and the development of groundbreaking therapies in the field of oncology.

Conclusion

Vera Mick's contributions to cancer treatment through her innovative patent and work at Affimed Therapeutics highlight her role as a leading inventor in the medical field. Her dedication to improving cancer therapies continues to inspire advancements in healthcare.